PozQoL Scale — Quality of life among people with HIV
The English version of PozQoL:
- was validated on a sample of 465 adult Australians living with HIV (2016-2018)
- was piloted in 10 Australian organisations that work with people living with HIV (2018-2019)
- is used in various settings
If you use the English version of PozQoL, we would love to hear from you.
The Implementation Kit was co-designed by organisations that were part of the PozQoL Usability Trial. It provides information about how to use the PozQoL Scale in practice.
The Pre-Post Group PozQoL Calculator is a spreadsheet that calculates and compares baseline and follow-up group PozQoL Scores.
Have you used the English version of the PozQoL Scale?
We would love to hear from you!
Your feedback and insights can help:
- improve the PozQoL Scale;
- make it easier to use;
- ensure that it is useful, relevant, and culturally appropriate; and
- support others who are thinking about using it.
Please feel free to contact us with your feedback or questions.
Are you a researcher working with English-speaking people with HIV?
We would love to hear about your research using PozQoL to look at the quality of life and experiences of English-speaking people with HIV.
If you are in a position to do so, we also encourage you to consider conducting further validation or implementation trials.
Copyright © La Trobe University, through its Australian Research Centre in Sex, Health and Society, 2021
Published in Australia by La Trobe University, Melbourne, VIC 3086, Australia
Enquiries: [email protected]
The PozQoL Scale and Tools are copyrighted.
Unless otherwise stated, the work is licensed under a Creative Commons Attribution-Non Commercial-Non Derivatives License
If you produce any written works or other media related to your use of PozQoL, you must cite PozQoL using the following reference:
Brown, G, Mikołajczak, G, Lyons, A, Power, J, Drummond, F, Cogle, A, Allan, B, Cooper, C & O’Connor, S 2018, ‘Development and validation of PozQoL: A scale to assess quality of life of PLHIV’, BMC Public Health, vol. 18, p. 527.